The U.S. Food and Drug Administration has declined to review Moderna's submission for a new influenza vaccine utilizing Nobel Prize-winning mRNA technology, as disclosed by the company on Tuesday. This development reflects the FDA's increased scrutiny of vaccines during Health Secretary Robert F. Kennedy Jr.'s tenure, particularly those employing mRNA technology, which he has been critical of both before and after assuming the role of the nation's top health official. Moderna received a "refusal-to-file" communication from the FDA, objecting to the methodology employed in a 40,000-person clinical trial that compared its novel vaccine to a standard flu shot currently in use. The trial indicated that the new...

U.S. figure skater Ilia Malinin, a 21-year-old from Virginia, recently made history at the Winter Olympics with a remarkable performance. During his gold medal-winning free skate, Malinin executed a backflip known as "the Bonaly flip" on one blade, a move previously banned but named after French skater Surya Bonaly. His flawless execution of this move marked the first legal performance of it at the Olympic Games, despite not earning him technical points. Malinin is renowned for being the first skater to successfully land the challenging quadruple axel jump in competition back in 2022 at the age of 17. This jump involves four and a half rotations in...

Canada is aiming to collaborate with Chinese companies over the next three years to develop an electric vehicle (EV) using Chinese expertise, a senior...

A company planning to construct its inaugural small modular nuclear reactor in New Brunswick is selling off some assets as uncertainties loom over its...